DK543987A - Quinolinbaseret forbindelse, fremgangsmaade til fremstilling heraf samt anticancermiddel omfattende samme - Google Patents

Quinolinbaseret forbindelse, fremgangsmaade til fremstilling heraf samt anticancermiddel omfattende samme

Info

Publication number
DK543987A
DK543987A DK543987A DK543987A DK543987A DK 543987 A DK543987 A DK 543987A DK 543987 A DK543987 A DK 543987A DK 543987 A DK543987 A DK 543987A DK 543987 A DK543987 A DK 543987A
Authority
DK
Denmark
Prior art keywords
anticancer
quinol
preparing
based compound
same
Prior art date
Application number
DK543987A
Other languages
English (en)
Other versions
DK543987D0 (da
Inventor
Masatoshi Yamato
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Publication of DK543987D0 publication Critical patent/DK543987D0/da
Publication of DK543987A publication Critical patent/DK543987A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK543987A 1986-10-17 1987-10-16 Quinolinbaseret forbindelse, fremgangsmaade til fremstilling heraf samt anticancermiddel omfattende samme DK543987A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61246776A JPS63101369A (ja) 1986-10-17 1986-10-17 インデノキノリン系化合物、その製造法及びその化合物を有効成分とする抗癌剤

Publications (2)

Publication Number Publication Date
DK543987D0 DK543987D0 (da) 1987-10-16
DK543987A true DK543987A (da) 1988-04-18

Family

ID=17153489

Family Applications (1)

Application Number Title Priority Date Filing Date
DK543987A DK543987A (da) 1986-10-17 1987-10-16 Quinolinbaseret forbindelse, fremgangsmaade til fremstilling heraf samt anticancermiddel omfattende samme

Country Status (12)

Country Link
US (1) US4826850A (da)
EP (1) EP0264124B1 (da)
JP (1) JPS63101369A (da)
KR (1) KR900003499B1 (da)
CN (1) CN1009826B (da)
AT (1) ATE73447T1 (da)
AU (1) AU598878B2 (da)
DE (1) DE3777319D1 (da)
DK (1) DK543987A (da)
ES (1) ES2033279T3 (da)
GR (1) GR3004353T3 (da)
NZ (1) NZ222185A (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01228965A (ja) * 1988-03-10 1989-09-12 Mect Corp 縮合キノリン系化合物及び縮合アクリジン系化合物、それらの製造法ならびにそれらの化合物を有効成分とする抗癌剤
JPH0692410B2 (ja) * 1988-08-30 1994-11-16 キッセイ薬品工業株式会社 新規なベンゾフロキノリン誘導体
JPH02256667A (ja) * 1988-12-27 1990-10-17 Masatoshi Yamato 縮合キノリン系化合物およびその製造方法
US5217961A (en) * 1988-12-27 1993-06-08 Mect Corporation Condensed quinoline system N-glycosides
AU640135B2 (en) * 1990-03-20 1993-08-19 Wellcome Foundation Limited, The Hetero polycyclic biocidal compounds and their use in medicine
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
US5681958A (en) * 1995-06-07 1997-10-28 Shaman Pharmaceuticals, Inc. Cryptolepine analogs with hypoglycemic activity
JP3141148B2 (ja) * 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
US5741926A (en) * 1997-02-12 1998-04-21 Shaman Pharmaceuticals, Inc. Aniline derivatives having antihyperglycemic activity
CN105622508B (zh) * 2015-12-22 2018-08-21 广西师范大学 一种新的[1,2,b]茚并喹啉类衍生物及其制备方法和在抗肿瘤药物中的应用
CN107325110B (zh) * 2017-07-21 2019-06-11 太原理工大学 一种四元杂环苯并噻吩并喹啉化合物及其合成方法
CN110256451B (zh) * 2019-07-15 2021-09-03 河南省科学院化学研究所有限公司 一种苯并呋喃并[2,3-b]喹啉衍生物的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200715A (en) * 1982-05-24 1986-06-11 New Zealand Dev Finance Acridine derivatives and pharmaceutical compositions containing such

Also Published As

Publication number Publication date
NZ222185A (en) 1990-07-26
EP0264124A1 (en) 1988-04-20
EP0264124B1 (en) 1992-03-11
DE3777319D1 (de) 1992-04-16
KR900003499B1 (ko) 1990-05-21
ES2033279T3 (es) 1993-03-16
DK543987D0 (da) 1987-10-16
US4826850A (en) 1989-05-02
JPS63101369A (ja) 1988-05-06
KR880005136A (ko) 1988-06-28
ATE73447T1 (de) 1992-03-15
AU598878B2 (en) 1990-07-05
CN87106996A (zh) 1988-06-15
GR3004353T3 (da) 1993-03-31
AU7987587A (en) 1988-04-21
CN1009826B (zh) 1990-10-03

Similar Documents

Publication Publication Date Title
FI901530A0 (fi) Menetelmä immunomoduloivien atsaspiraanien valmistamiseksi
HUT37780A (en) Process for producing n-/4-piperidyl/-substituted bicyclic condensed 2-imidazolyl-amine derivatives and pharmaceutical compositions containing them as active agents
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
DK543987D0 (da) Quinolinbaseret forbindelse, fremgangsmaade til fremstilling heraf samt anticancermiddel omfattende samme
IL84917A0 (en) Quinolinone derivative,its preparation and pharmaceutical compositions containing it
ATE179169T1 (de) Prostaglandinanaloge
DK546489D0 (da) Thienopyridin-mevalonolactoner, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat omfattende samme
PL286043A1 (en) Method for manufacturing new proteins
EP0168921A3 (en) Chemical compounds
EP0245902A3 (en) Benzothiazinone derivatives
HUT34478A (en) Process for producing hexahydro-pyrrolo/2.1-a/isoquinoline derivatives and pharmaceutical compositions containing them
DK424888D0 (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
ES2078288T3 (es) Isomeros de 1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-5-nitropiridina-3-carboxilato de 1-azabiciclo(2.2.2)oct-3-ilo.
GR3002699T3 (en) Process for stabilising procaterol
DK437787A (da) 2,6-bis-(chlormethyloxy-carbonyloxymethyl)-pyridinsamt fremgangsmaade til fremstilling deraf
TH5414EX (th) สารประกอบควิโนลิน
ES540693A0 (es) Un procedimiento de preparar sales quinato de alfa-2-piperi-dinil-2,8-bis(trifluorometil)-4-quinolino-metanol
BG95329A (bg) Метод за получаване на производни на хинолина

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment